![Study Results & Research Projects Study Results & Research Projects](https://webarchive.library.unt.edu/eot2008/20090116151512im_/http://ntp-server.niehs.nih.gov/images/template/subMastHead_studyResults.gif)
Summaries & Associations of Study Results
Summaries & Associations of Study Results
Home » Study Results & Research Projects » Summaries & Associations of Study Results » TR-341 Nitrofurantoin
CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
---|---|---|---|---|
NITROFURANTOIN 67-20-9 |
04/18/88 | URINARY ANTIBACTERIAL AGENT. (TDB) | Dosed-Feed FR: 0,600,1300, MR&M: 0,1300,2500 PPM/50 PER GROUP | Southern Research Institute |
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
MR: SOME EVIDENCE | KIDNEY TUBULAR CELL: ADENOMA 0/50 1/50 2/50 OR CARCINOMA 0/50 0/50 1/50 COMBINED 0/50 1/50 3/50 | |||
MAY HAVE BEEN RELATED: | BONE: OSTEOSARCOMA 0/50 1/50 2/50 | |||
SUBCUTANEOUS TISSUE: FIBROMA 0/50 5/50 4/50; FIBROSARCOMA 1/50 2/50 1/50 | ||||
NON-NEOPLASTIC LESIONS: | KIDNEY: NEPHROPATHY, CHRONIC 50/50 48/50 48/50 | |||
TESTES: DEGENERATION 0/50 0/50 36/50 | ||||
FR: NO EVIDENCE | ||||
MM: NO EVIDENCE | ||||
NON-NEOPLASTIC LESIONS: | TESTES: GERMINAL EPITHELIUM, DEGENERATION 0/49 3/49 23/50 | |||
FM: CLEAR EVIDENCE | OVARY: TUBULAR CELL ADENOMA 0/50 0/50 5/50; BENIGN MIXED TUMORS 0/50 0/50 4/50; GRANULOSA CELL TUMOR 0/50 3/50 2/50 | |||
NON-NEOPLASTIC LESIONS: | OVARY: ATROPHY 0/50 48/50 49/50 | |||
ADRENAL GLAND: SPINDLE CELL, HYPERPLASIA 3/50 41/50 45/50 |
Web page last updated on February 10, 2006
The National Institute of Environmental Health Sciences is one of the National Institutes of Health within the U.S. Department of Health and Human Services. The National Toxicology Program is headquartered on the NIEHS campus in Research Triangle Park, NC.